密爾克衞(603713.SH)漲停 定增獲高毅等多家明星機構認購
格隆匯3月19日丨密爾克衞(603713.SH)漲停,報117.67元,市值194億元。公司昨晚披露定增結果顯示,發行價格112.85元/股(昨日收市價為106.97元),募集資金總額約11億元,最終確認獲配對象為11個,其中平安證券獲配8000萬元,摩根士丹利獲配5100萬元,太平洋人壽保險獲配3億元,高毅資管獲配5000萬元,高盛獲配1.25億元,太平洋財產保險獲配1.12億元。公司稱,隨着募資到位募投項目的建成,公司盈利能力將進一步得到提高,發展潛力也將隨之增強。本次發行使得公司整體資金實力和償債能力得到提升,資本結構得到優化,增強公司抵抗市場風險的能力,進一步提高公司的整體競爭力,也為公司後續發展提供有效的保障。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.